Cardiff Oncology
Davis Klein is currently employed as a Senior Research Associate at Cardiff Oncology. Prior to this, they worked as a Cell Modeling Specialist at Altos Labs and as a Research Assistant at Salk Institute for Biological Studies. Davis also held a position as a Researcher at SDSU College of Sciences. They completed their Bachelor's degree in Biochemistry at SDSU College of Sciences in 2022, with Student Research completed in Dr. Chris Harrison's lab.
Cardiff Oncology
Cardiff Oncology is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need. Our goal is to overcome resistance, improve response to treatment and increase overall survival. We are developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.